Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates

COVID-19 vaccines emerging from different platforms differ in efficacy, duration of protection, and side effects. To maximize the benefits of vaccination, we explored the utility of employing a heterologous prime-boost strategy in which different combinations of the four types of leading COVID-19 va...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qian, Mao, Qunying, An, Chaoqiang, Zhang, Jialu, Gao, Fan, Bian, Lianlian, Li, Changgui, Liang, Zhenglun, Xu, Miao, Wang, Junzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009122/
https://www.ncbi.nlm.nih.gov/pubmed/33691606
http://dx.doi.org/10.1080/22221751.2021.1902245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009122/
https://www.ncbi.nlm.nih.gov/pubmed/33691606
http://dx.doi.org/10.1080/22221751.2021.1902245

Ejemplares similares